Skip to main content
. Author manuscript; available in PMC: 2012 Oct 17.
Published in final edited form as: Clin Lung Cancer. 2010 Jul 1;11(4):228–237. doi: 10.3816/CLC.2010.n.029

Fig 2.

Fig 2

T-cell recognition requires an MHC molecule with a T-cell-specific tumor-associated antigen (TAA) peptide in its cleft. This triggers immune-mediated killing either through Fas or the release of granzymes. TCR T-cell receptor, LFA-1 lymphocyte function-associated antigen-1, Fas-L Fas ligand. (Figure courtesy of NIH Medical Arts.)